⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001838041

Bruns Ingmar

Reports to the SEC for 2 companies · SAN DIEGO, CA

Transactions

9

Companies

2

Filings

7

CIK

0001838041

Forms 4 and 5

Insider transactions

9 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	ZNTLZentalis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+9,727 sh	$2.18	+$21.2K	43,059
2026-02-09	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−335 sh	$2.39	−$801.622	33,332
2026-02-06	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,962 sh	$2.43	−$7,196.771	33,667
2026-01-08	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+365K sh	—	—	365,000
2025-02-06	ZNTLZentalis Pharmaceuticals, Inc.P Purchase	Chief Medical Officer	PPurchase	+20K sh	$2.28	+$45.7K	36,629
2025-02-03	ZNTLZentalis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+16.6K sh	—	—	16,629
2025-02-03	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+16.6K sh	—	—	16,629
2024-12-02	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+713K sh	—	—	712,650
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−400K sh	—	—	0

Recent filings

7

Accepted (ET)
Oct 14
Bruns Ingmar0001628280-26-064317
SEC(opens sec.gov)
Feb 104
Bruns Ingmar0001838041-26-000004
SEC(opens sec.gov)
Jan 94
Bruns Ingmar0001838041-26-000002
SEC(opens sec.gov)
Feb 124
Bruns Ingmar0001725160-25-000047
SEC(opens sec.gov)
Feb 54
Bruns Ingmar0001725160-25-000037
SEC(opens sec.gov)
Dec 34
Bruns Ingmar0001725160-24-000190
SEC(opens sec.gov)
Nov 194
Bruns Ingmar0001104659-21-141741
SEC(opens sec.gov)

Companies

2

Address

C/O ZENTALIS PHARMACEUTICALS, INC. 10275 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121